Cost-effectiveness of the Recombinant Zoster Vaccine Among People Living with Human Immunodeficiency Virus in Japan [VHRI Volume 44, November 2024, 101025]

Value Health Reg Issues. 2024 Nov:44:101061. doi: 10.1016/j.vhri.2024.101061.

Authors

So Sato¹, Takaaki Konishi¹, Hiroyuki Ohbe¹, Hideo Yasunaga¹

Affiliation

¹ Department of Clinical Epidemiology and Health Economics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

PMID: 39477630
DOI: 10.1016/j.vhri.2024.101061

No abstract available

Publication types

Published Erratum